Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Clinical science

• Publication date

  1992-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/CS0830205PMID 1327637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropeptide Y and neuron‐specific enolase levels in benign and malignant pheochromocytomas

  1990cited by this paper
• Release of neuropeptide Y from pheochromocytomas.

  1990cited by this paper
• Radioimmunoassay of neuropeptide Y (NPY) in biological fluids. Circulating NPY levels depend on renal function.

  1989cited by this paper
• Elevated serum neuron‐specific enolase in patients with malignant pheochromocytoma

  1988cited by this paper
• Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.

  1987cited by this paper
• Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromocytoma and chronic renal failure.

  1987cited by this paper
• Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.

  1987cited by this paper
• Synergistic pressor action of neuropeptide Y and norepinephrine in conscious rats.

  1986cited by this paper
• Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.

  1986cited by this paper
• An immunoradiometric assay for the measurement of neuropeptide Y in plasma.

  1985cited by this paper
• Neuropeptide Y in bovine adrenal glands: distribution and characterization.

  1985cited by this paper
• Co-release of neuropeptide Y and catecholamines during physical exercise in man.

  1985cited by this paper
• Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats.

  1985cited by this paper
• Norepinephrine-like effects of neuropeptide Y on LH release in the rat.

  1984cited by this paper
• Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue.

  1984cited by this paper
• Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels

  1984cited by this paper
• Current concepts. Pheochromocytoma: diagnosis, localization and management.

  1984cited by this paper
• Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine.

  1984cited by this paper
• Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat.

  1984cited by this paper
• Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.

  1983cited by this paper
• Neuropeptide Y distribution in human brain

  1983cited by this paper
• High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.

  1982cited by this paper
• Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens.

  1982cited by this paper
• Neuropeptide Y: complete amino acid sequence of the brain peptide.

  1982cited by this paper
• Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

  1982cited by this paper
• Neuron-specific enolase is produced by neuroendocrine tumours.

  1981cited by this paper
• Incorrect least-squares regression coefficients in method-comparison analysis.

  1979cited by this paper
• CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PHEOCHROMOCYTOMA: A REVIEW OF 76 CASES.

  1964cited by this paper
• Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

  1962cited by this paper

• Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure

  2019cites this paper
• Pheochromocytoma in Urologic Practice.

  2016cites this paper
• Ubiquitous expression and multiple functions of biologically active peptides.

  2015cites this paper
• Pheochromocytomas: diagnosis and treatment

  2015cites this paper
• Phaeochromocytoma: State-of-the-art

  2010cites this paper
• Expression of peptide YY in human brain and pituitary tissues.

  2008cites this paper
• Secondary Hypertension: Pheochromocytoma

  2007cites this paper
• Elevated Plasma Immunoreactive Concentrations and Its Increased Patients with Advanced Diabetic Neuropeptide Y Urinary Excretion in Nephropathy

  2006cites this paper
• High Plasma Levels of Human Chromogranin a and Adrenomedullin in Patients with Pheochromocytoma

  2005cites this paper
• Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.

  2003cites this paper
• Adrenomedulin from a Pheochromocytoma to the Eye : Implications of the Adrenomedulin Research for Endocrinology in the 21 st Century

  2003cites this paper
• A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma.

  2003cites this paper
• Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century.

  2001cites this paper
• Production and secretion of two vasoactive peptides, adrenomedullin and endothelin-1, by cultured human adrenocortical carcinoma cells.

  2000influential citation
• Synthesis, Storage, and Secretion of Adrenal Medullary Hormones: Physiology and Pathophysiology

  2000cites this paper
• Acute and Chronic Role of 5-HT3 Neuronal System on Behavioral and Neuroendocrine Changes Induced by Intravenous Cholecystokinin Tetrapeptide Administration in Humans

  1999cites this paper
• Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy.

  1999cites this paper
• Production and secretion of endothelin-1 by cultured choroid plexus carcinoma cells.

  1998cites this paper
• Expression of adrenomedullin and adrenomedullin mRNA in ectopic ACTH-secreting tumors.

  1998cites this paper
• Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.

  1997cites this paper
• Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure.

  1997cites this paper
• Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors.

  1997cites this paper
• Pheochromocytoma and primary aldosteronism: diagnostic approaches.

  1997cites this paper
• Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.

  1997cites this paper
• Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome.

  1995cites this paper
• Neuropeptides in neuroblastomas and ganglioneuromas.

  1995cites this paper
• Funny Spells in Neuroendocrine Disorders

  1995cites this paper
• Neuropeptide Y: a possible role in hypertension?

  1995cites this paper
• Neurobiology and clinical aspects of neuropeptide Y.

  1995cites this paper
• Chapter 18 Neuropeptides in neuroblastomas and ganglioneuromas

  1995cites this paper
• NEUROPEPTIDE Y IN CORTISOL‐INDUCED HYPERTENSION IN MALE VOLUNTEERS

  1994cites this paper
• Neuropeptides in the sympathetic system: Presence, plasticity, modulation, and implications

  1994cites this paper
• Octreotide for treatment of intraoperative hypotension due to an unexpected neuroblastoma in an adult.

  1994cites this paper